Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Central Nervous System Neoplasm

3-iodobenzylguanidine has been researched along with Central Nervous System Neoplasm in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aktolun, C; Castellani, MR1
Gelfand, MJ; Parisi, MT; Sharp, SE; Shulkin, BL; Yanik, GA1
Liu, B; Servaes, S; Zhuang, H1
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G1
Charron, M1
DuBois, SG; Matthay, KK1
Bomanji, JB; Gains, JE; Gaze, MN; Walker, C1

Reviews

6 review(s) available for 3-iodobenzylguanidine and Central Nervous System Neoplasm

ArticleYear
Functional-metabolic imaging of neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Medical Oncology; Neuroblastoma; Prognosis; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging

2013
Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Central Nervous System Neoplasms; Child; Dose Fractionation, Radiation; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Pheochromocytoma; Radiometry; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging

2013
PET/CT imaging in neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed

2013
Contemporary approach to diagnosis and treatment of neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Animals; Bone and Bones; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Diagnostic Imaging; Disease Models, Animal; Female; Humans; Infant; Kinetics; Male; Medical Oncology; Mice; Neuroblastoma; Octreotide; Patient Safety; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Remission Induction; Sensitivity and Specificity; Tissue Distribution

2013
131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Biomarkers; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Humans; Medical Oncology; Neuroblastoma; Radiopharmaceuticals; Risk; Treatment Outcome

2013
Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Medical Oncology; Neuroblastoma; Radiation-Sensitizing Agents; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Risk; Time Factors; Treatment Outcome

2013

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Central Nervous System Neoplasm

ArticleYear
Theranostic role of MIBG in neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Humans; Medical Oncology; Neuroblastoma; Peptides; Positron-Emission Tomography; Radioisotopes; Tomography, X-Ray Computed

2013